were screened. [13] [14] [15] The existing body of research on PD epidemiology suggests that disease frequency peaks in the age-group 80-89 years old and then declines; 5, 16, 17 other studies have found the highest agespecific prevalence rates among the oldest groups studied. 14, 15, 18 A much-debated question is whether gender is a risk factor of PD. Males have been related to higher age-adjusted prevalence rates in many studies; in only a few studies did females have higher rates. 3, 7, 11, 14, 15, [17] [18] [19] Several other studies did not observe a statistically significant difference between gender and adjusted PD prevalence rates. 4, 6, 20 Results on the role of urban or rural living on prevalence of PD are controversial. 4, 6, 7, 10, 15, 16, 20 The heterogeneity in prevalence rates across studies has at least partially been attributed to differences in case ascertainment and diagnostic accuracy. Therefore, repeated studies of a population using the same case ascertainment methodology and diagnostic criteria are very valuable to evaluate epidemiological trends. There have only been a few repeated epidemiological studies of PD prevalence. 5, 7, 21, 22 The first epidemiological study in Estonia was conducted in 1996
and reported an age-adjusted PD prevalence rate of 152/100 000 persons, 6 which was similar to the rates of several other European community-based PD studies conducted during the 1990s, that is, 135-183/100 000. [7] [8] [9] 22 Current study enabled us to evaluate the dynamics of PD epidemiology using a similar case ascertainment methodology on the same population.
This study of Tartu City and County aimed to (i) determine the current frequency of PD among the population; (ii) evaluate prevalence trends by comparing the results to those of a survey conducted among the same population approximately 20 years ago; and (iii) describe the clinical profile of patients with PD.
| ME THODS

| Area and population
Tartu County is located in South Estonia and had a population of 152 188 (71 395 men, 80 793 women) during the last census in January 2014. 23 The county is administratively divided into 3 urban and 19 rural municipalities and covers a total of 2993 km 2 . Tartu, the second largest city of Estonia, is the administrative center of Tartu
County. The male-female proportion in the entire country was the same as in Tartu in 2014, that is, 43% men and 53% women. 12.4% of individuals were over 70 years old, there were twice as many women than men in that age (16% of women vs 8% of men) in Tartu. 23 Tartu University Hospital is the regional hospital of South Estonia, with a well-developed digital patient record system that is connected to the national e-Health system, a platform that holds all the medical information of Estonian inhabitants. In addition to Tartu University Hospital, there is 1 local hospital that provides outpatient and inpatient services for neurological patients, and 10 nursing homes and hospitals. In 2013, there were 61 family doctor's offices in Tartu County. In Estonia, patients with a possible PD are referred to a neurologist who confirms the diagnosis and starts the initial treatment that will be followed by a family doctor. 
| Study design and ethical issues
| Case ascertainment and diagnostic criteria
The following information from all available sources was regularly Those who refused to participate were unreachable or had died before their identification, but were alive on the prevalence day and were enrolled as prevalent cases if they had a confirmed diagnosis of PD based on medical records. Patients with other parkinsonian syndromes including secondary or atypical parkinsonism were excluded from the PD sample.
| Data collection and clinical examination
Participants or their caregivers were informed about the study be- Unified Rating Scale (MDS-UPDRS), 26 Hoehn and Yahr Rating Scale (HY), 27 and Schwab and England's Activities of Daily Living Scale (SE-ADL). 28 In addition, the Mini-Mental State Examination (MMSE) 29 was performed as a screening test of cognitive status, and the Beck Depression Inventory (BDI) 30 for depression.
| Statistical analysis
Age-, gender-, and living area-specific crude prevalence rates were calculated based on the number of PD cases on prevalence day and the number of inhabitants of the county of Tartu according to the population census on January 1st, 2014. Crude rates were adjusted for age structure of Estonian population on January 1st, 2014, using the direct method of standardization. To compare our prevalence figures to the previous epidemiological study in Estonia, an additional age adjustment was made according to the age-structure of Estonia in 1989, which was the reference population used in the study by Taba and Asser. 6 Furthermore, using the European 2011 standard population as a reference, 31 a corresponding age-adjusted prevalence rate was also calculated.
95% confidence intervals for the prevalence rates were calculated assuming the Poisson distribution of observed cases. The differences in crude prevalence rates between the groups were statistically evaluated using Poisson regression analysis. The differences in age-adjusted prevalence rates between the groups and between 2 time-points were statistically evaluated using the Z test. Familywise error rate was controlled with Bonferroni method. All statistical analyses were performed in R version 3.3.3.
| RE SULTS
The overall study population from all sources with suspected PD in Tartu County comprised 1011 subjects ( Figure 1 ). From medical records, 455 patients were found, and a PD diagnosis confirmed in 88% of cases. From the additional search of the EHIF, 556 cases were found, but only 32% had a confirmed diagnosis of PD and were enrolled in our study.
A total of 431 patients (160 men, 271 women) fulfilled the study criteria and were included into the prevalence analysis. Of them, 71% lived in urban areas and 29% in rural areas. Without the use of the EHIF data, a total number of 321 (120 men, 201 women) patients with PD were identified. On prevalence day, the mean age of participants was 77.4 ± 9 years, and the mean duration of the disease was 7.0 ± 5.9 years. The crude and age-adjusted PD prevalence rates are shown in Table 1 . The total crude prevalence rate was higher for women than for men. There was no significant difference F I G U R E 1 Flow diagram of the case ascertainment procedure. CBD, corticobasal degeneration; EPS, extrapyramidal syndrome; LBD, dementia with Lewy bodies; MSA, Multiple system atrophy; PD, Parkinson′s disease; PSP, progressive supranuclear palsy between age-adjusted prevalence rates of men and women (rate ratio [RR] = 0.83, P = .07; Table 1 ). In terms of living area, no significant difference in adjusted prevalence rates of PD was shown between urban and rural populations (RR = 1.02, P = .83). We found a trend of increasing age-specific prevalence with age for both genders, peaking in the age-group 80-84 years old per women and 85+ years old per men, followed by a significant decline among the most elderly women but not the men (Figure 2 ). After age-adjustment to the European 2011 standard population, the overall prevalence rate was 324/100 000 people.
The age-specific and total crude rates of current study and the study conducted in Estonia in 1996 are shown in Table 2 . Comparison of the adjusted prevalence rates of the 2 Estonian studies is shown in Table 3 . We found that the overall age-adjusted prevalence rate was significantly higher in the current study (RR = 1.30, P = .004), and among men (RR = 1.44, P = .0018; Table 3 ).
Of the 431 patients included in the prevalence analysis, 84% are shown in Table 4 . Mean age at PD onset was 67.9 ± 9.9 years 
| D ISCUSS I ON
The first aim of this study was to determine the current frequency of PD in Estonia. Age-adjusted prevalence rates of PD in several other community-based studies as well as in our previous study that used the same diagnostic criteria have reported remarkably lower rates than the current study, ranging from 109 to 183/100 000. 3, 4, [6] [7] [8] However, the use of different case ascertainment methods and standard populations sets limits to the comparability of prevalence estimates reported by various studies.
In line with the literature, PD prevalence increased continuously with age among both men and women. 5, 7, 8, 10, [13] [14] [15] 18 Although the crude prevalence rate was significantly higher for women, no difference of the age-adjusted prevalence rates was evidenced between men and women, the latter finding being in line with a few earlier studies. 4, 6, 20 The discrepancy of the crude and adjusted prevalence rates in our study might result from the predominance of women in the oldest age-groups in Estonia, that is, in 2014, there were 3.8 times more women than men aged 85 years and more. The highest age-specific crude rate for women in the subgroup of 80-84-year-old people had big influence on the crude measure, while the standardization removed the difference coming from the population P-value below .0125 (after Bonferroni correction) was considered significant.
F I G U R E 2
Age-specific prevalence rates of PD for all patients and according to gender on the prevalence day of 1st October, 2013. PD, Parkinson′s disease structure. Results of an incidence study that is ongoing at this time in Tartu County should give more precise answers to the matter of risks related to gender and PD in Estonia.
Our study did not demonstrate a statistically significant difference between the prevalence rates of PD among urban and rural populations, a finding that contrasts with the results of some Scandinavian studies, 7, 10 but is supported by several other previous surveys. 4, 16, 20 However, a trend of higher incidence rates of PD among the urban compared to the rural population of Tartu County was found in a previous PD incidence study. 32 A nested case-control study by Tanner et al. 33 supported the role of pesticides in PD pathophysiology; these environmental factors have long been linked with the disease's etiology. The use of pesticides has not been extensive in Estonia, supported by only a minority (3.6%) of patients in our study indicating that they had been exposed to these chemicals over their lifetime, a rate that is lower than reported in one other study. 34 Exposure to chemical solvents or paints was reported by a higher number of patients (14%), but these environmental factors are less linked with living area than occupation.
With respect to the second research question regarding PD prevalence over time, we found that the overall disease prevalence in Estonia has risen from 152/100 000 in 1996 to 197/100 000 in 2013. Age-specific crude rates in the older age-groups have grown considerably. Considering the demographical situation in Tartu County, as well as in the entire country in 1996 and 2013, the changes have been substantial. An increase in the population proportion of older age-groups and a decrease in younger groups are notable. We believe that longer life expectancy nowadays compared to 20 years ago has an important contribution to the higher frequency of PD.
Life expectancy of men was 64 years in 1996 and 72 years in 2014;
and for women 75 years in 1996 and 81 years in 2014. 23 The most striking aspect to emerge from the results is that the prevalence of PD has increased mainly among men. Men's life expectancy is now longer due to better health behaviors and improved medical care.
Another reason for the higher prevalence of PD could be related to awareness. First, knowledge of the management of PD has improved remarkably among family doctors and neurologists due to continuous research on the disease, and new insights into the clinical heterogeneity and therapeutic approaches to PD have been adopted into clinical practice. Second, resulting from the improved general awareness of the disease in society, patients themselves are more attentive to the physical signs and seek specialist consultation. The internet might have a major role in spreading information on PD among society; this source was almost unavailable 20 years ago. 35 Men's health receives more attention than decades ago, resulting in improved medical care. It could be possible that 20 years ago, an undetermined number of actual cases of PD were missed, because people were less likely to seek help from the medical system.
In the current study, we used the same diagnostic criteria and a similar case ascertainment methodology as the previous epidemiological study by Taba and Asser, 6 except that the EHIF database was used as an additional source in the current study, which found a high number of persons with suspected PD (coded as G20 in ICD-10). However, quite a large proportion of them were removed from the study, as their initial family doctor's diagnosis was not confirmed by a specialist (Figure 1 ).
The third aim of this research was to describe the natural history of PD. The proportion of patients moderately or severely affected by the disease was higher in the current study than in the previous study in Estonia, 6 as well as in prevalence surveys conducted elsewhere. 5, 9, 16 First, this could be associated with the relatively high proportion of patients who were visited at their homes or in nursing institutions, indicating that they were bed-ridden or had otherwise serious problems with walking or general health. Second, patients in our cohort were older and had a longer disease duration compared to other studies. 5, 6 Approximately, half of our patients presented depressive symptoms and a quarter were cognitively impaired, which makes the management of this chronic disorder even more challenging.
The main strength of our study was the nearly complete identification of PD cases, based on all available sources over a long time frame, including the database of the EHIF that includes all recorded cases in the country. Second, the evaluation of the participants was thorough, including the collection of sociodemographic and disease-related data from quite a large sample of study subjects.
Furthermore, wide-ranging clinical aspects were assessed based on validated clinometric scales and questionnaires. We think that the profile of our study participants is generalizable to the Estonian PD population as a whole. Last, given that there are only a few repeated epidemiological PD studies conducted on the same population at different time periods, our study provides valuable information about temporal trends of PD prevalence.
Some limitations of this study need to be taken into account when interpreting the findings. The first limitation concerns the small but existing proportion of patients whose diagnosis was only obtained through a review of medical records, that is, they were not personally examined during the study. Another limitation is the extra source list used in our repeat study, as data from the EHIF were not used in the previous PD prevalence study, thus lowering the comparability of the 2 studies.
In summary, the current research extends our knowledge of in- 
CO N FLI C T O F I NTE R E S T S
The authors declare that they have no financial or non-financial competing interests.
O RCI D
L. Kadastik-Eerme http://orcid.org/0000-0002-9788-9402
